Living Donor Navigation for Kidney Disease
(PILOT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if the Living Donor Navigator (LDN) program, delivered via tele-health, can assist more individuals with end-stage kidney disease in finding living kidney donors. The trial compares in-person sessions at transplant centers with virtual sessions through a local health department. It suits English-speaking patients with end-stage kidney disease who are beginning the transplant process and wish to explore living donation options. As an unphased trial, it provides patients a unique opportunity to contribute to innovative research that could enhance access to living kidney donors.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the Living Donor Navigator Program is safe?
Research has shown that the Living Donor Navigator (LDN) Program assists kidney transplant candidates and their potential donors throughout the donation process. This program offers education and support, either in person or via tele-health services.
The LDN program does not include any medical treatments or medications, so typical clinical trial safety concerns do not apply. Instead, it focuses on providing guidance and support to simplify the living kidney donation process.
Studies suggest that offering the program through tele-health extends its reach to people in various locations, enhancing accessibility. No reports indicate any safety issues with the program, as it is purely educational and not a medical treatment. Consequently, participants seem to receive it well, and it poses no risks to physical health.12345Why are researchers excited about this trial?
Researchers are excited about the Living Donor Navigator Program because it introduces a personalized approach to finding and guiding living kidney donors, which is a fresh take on the often complex and daunting transplant process. Unlike traditional methods, which can leave patients and potential donors to navigate the system on their own, this program offers dedicated support through either in-person or tele-health sessions. The navigators provide step-by-step assistance, ensuring both transplant candidates and donors have a streamlined and personalized experience. This could significantly increase the number of successful transplants by making the donor process more accessible and less intimidating.
What evidence suggests that the Living Donor Navigator Program is effective for kidney disease?
Research has shown that the Living Donor Navigator (LDN) program, available to participants in this trial either in-person or through tele-health, significantly increases the likelihood of finding a living kidney donor. One study found that people in the program were seven times more likely to receive a kidney from a living donor compared to those not in the program. The tele-health version, another arm of this trial, has proven equally successful, with early results indicating a seven-fold increase in approved donors for participants. Both versions of the program guide transplant candidates and potential donors through the donation process, making it easier and more personal. This approach removes obstacles and makes living kidney donation more accessible.678910
Who Is on the Research Team?
Vineeta Kumar, MD
Principal Investigator
University of Alabama at Birmingham
Are You a Good Fit for This Trial?
This trial is for adults over 18 with end-stage kidney disease who are evaluating their options for a kidney transplant. It's open to English speakers, including deaf individuals with interpreters. People unwilling to consider living donors or those under 18 cannot participate.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Living Donor Navigator (LDN) program, consisting of four educational sessions over two months, either in-person or via tele-health.
Follow-up
Participants are monitored for the number of live donor screenings and approvals within 3 months.
What Are the Treatments Tested in This Trial?
Interventions
- Living Donor Navigator Program
Trial Overview
The study tests if a Living Donor Navigator Program delivered via tele-health can increase living kidney donations compared to standard care. Participants will be randomly assigned to receive the program immediately or after a delay.
How Is the Trial Designed?
2
Treatment groups
Active Control
The LDN program is designed to help transplant candidates find potential donors, and guide potential living donors through the evaluation/ donation process. The LDN program consists of four educational sessions, with each session building on the last. Each educational session lasts approximately 2 hours and is held once every other week for two months. Each LDN session will be conducted by a living donor navigator. As potential living donors are identified, the living donor navigators will work closely with the potential donors to guide them through each step of the evaluation/donation process to ensure streamlined medical services and a personalized experience. Individuals randomized to LDN in-person will receive the program locally at the transplant center.
The LDN program is designed to help transplant candidates find potential donors, and guide potential living donors through the evaluation/ donation process. The LDN program consists of four educational sessions, with each session building on the last. Each educational session lasts approximately 2 hours and is held once every other week for two months. Each LDN session will be conducted by a living donor navigator. As potential living donors are identified, the living donor navigators will work closely with the potential donors to guide them through each step of the evaluation/donation process to ensure streamlined medical services and a personalized experience. Individuals randomized to LDN tele-health will receive the program virtually at a local health department within the Alabama Department of Public Health's tele-health network.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Published Research Related to This Trial
Citations
Interpersonal Connections are Important for Virtual Kidney ...
... people who chose to participate in the program were 7 times more likely to receive a living donor kidney transplant. Patients with end-stage kidney disease ...
2.
researchgate.net
researchgate.net/figure/Study-population-flow-diagram-LDN-Living-Donor-Navigator_fig2_332230180Study population flow diagram. LDN, Living Donor Navigator.
The aim of this study was to describe the perspectives and experiences of Indigenous kidney transplant candidates and recipients, living kidney donors, and ...
Kidney transplant candidacy evaluation and waitlisting ...
Our study suggests that programs that do not have stringent BMI thresholds may have higher rates of living donor and preemptive transplantation as well as lower ...
Enhanced Advocacy and Health Systems Training through ...
A novel program designed to promote both advocacy and systems training among transplant candidates and their potential living kidney donors.
Evaluation of Kidney Donors: Core Curriculum 2018
This installment of AJKD's Core Curriculum in Nephrology provides readers with the tools necessary for proper evaluation of living kidney donor candidates.
Greater Community Vulnerability is Associated with Poor ...
The Living Donor Navigator (LDN) Program helps patients with ESKD identify living kidney donors and helps living donors navigate the complex evaluation process.
7.
kidneyfund.org
kidneyfund.org/article/american-kidney-funds-5th-annual-living-donor-report-card-reveals-mixed-progress-calls-urgent-actionLiving Donor Protection Report Card
Between 2012 and 2022, the annual count of those on dialysis who received a kidney transplant increased by 52%; most of this increase was ...
Increasing Living Kidney Donors in Alabama
The Living Donor Navigator Program aims to increase kidney transplants in Alabama by removing barriers to living kidney donations for potential recipients and ...
Self-advocacy is associated with lower likelihood of living ...
Self-advocates had lower likelihood of LDKT compared to patients with an advocate. Having a spouse/significant other advocate was significantly associated with ...
Patient Navigators for CKD and Kidney Failure: A Systematic ...
We performed a systematic review to summarize patient navigator program design, evidence, and implementation in kidney disease.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.